搜索筛选:
搜索耗时0.0893秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
Bronchoscopic biopsy for diagnosis of lung cancer in the absence of visible endobronchial abnormalit
[期刊论文] 作者：Hua Zheng,Baohua Lu,Qunhui Wang,Fanbin Hu,Weimin Ding,Baolan Li,,
来源：Oncology and Translational Medicine 年份：2016
Objective Bronchoscopy has been extensively used in the diagnosis of respiratory diseases, and particularly, malignant diseases. However, endoscopists do not no...
Icotinib, an EGFR-TKI, for the treatment of brain metastases in non-small cell lung cancer:a retrosp
[期刊论文] 作者：Qunhui Wang,Hua Zheng,Ying Hu,Baohua Lu,Fanbin Hu,Hongmei Zhang,Baolan Li,,
来源：Oncology and Translational Medicine 年份：2016
Objective Treatment of brain metastases from non-small cell lung cancer(NSCLC) is a challenge because of the poor prognosis. Icotinib is a new type of oral epid...
The expression of vascular endothelial growth factor(VEGF)/endostatin(ES)and VEGF receptor 2(VEGFR2)
[期刊论文] 作者：Yuan Yang,Baohua Lu,Baolan Li,Weiying Li,Mei Jiang,Wentao Yue,Qunhui Wang,Tongmei Zhang,
来源：肿瘤学与转化医学:英文版 年份：2021
Objective The aim of our study was to detect the expression of angiogenesis inhibitory proteins and angiogenesis promotive proteins in the postoperative tumor tissue of non-small cell lung cancer(NSCLC)patients.We also investigated the rela......
The expression of vascular endothelial growth factor (VEGF)/ endostatin (ES) and VEGF receptor 2 (VE
[期刊论文] 作者：Yuan Yang,Baohua Lu,Baolan Li,Weiying Li,Mei Jiang,Wentao Yue,Qunhui Wang,Tongmei Zhang,
来源：肿瘤学与转化医学（英文版） 年份：2021
Objective The aim of our study was to detect the expression of angiogenesis inhibitory proteins and angiogenesis promotive proteins in the postoperative tumor t...
Anlotinib as third-line treatment in patients with refractory advanced non-small cell lung cancer: a
[会议论文] 作者：Baohui Han,Jiang Liyan,Rong Li,Yizhuo Zhao,Kai Li,Baolan Li,Ying Cheng,Jianying Zhou,You Lu,Yuankai Shi,
来源：第十二届中青年呼吸学者论坛 年份：2015
...
Anlotinib as third-line treatment in patients with refractory advanced non-small cell lung cancer: a
[会议论文] 作者：Rong Li,Kai Li,Yizhuo Zhao,Baolan Li,Ying Cheng,Jianying Zhou,You Lu,Yuankai Shi,Zhehai Wang,Jiang Liyan,
来源：第十二届中青年呼吸学者论坛 年份：2015
Background: Anlotinib is a multitargeted tyrosine-kinase inhibitor (TKI).We perform a randomised,double-blind, placebo-controlled, phase 2 trial to assess the efficacy and safety of anlotinib in patie...
相关搜索：
